FierceBiotech ٦ يناير ٢٠٢٦ Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator
FierceBiotech ٦ يناير ٢٠٢٦ Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact
FierceBiotech ٦ يناير ٢٠٢٦ FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection
FierceBiotech ٦ يناير ٢٠٢٦ UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices
FierceBiotech ٥ يناير ٢٠٢٦ Biobeat Technologies drums up $50M for its cuffless blood pressure monitor
FierceBiotech ٥ يناير ٢٠٢٦ Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit
FierceBiotech ٥ يناير ٢٠٢٦ Abbott launches AI-based Libre Assist, its new in-app feature for meal planning
FierceBiotech ٥ يناير ٢٠٢٦ Cash-strapped TME Pharma loses partner, prompting eye drug strategy rethink
FierceBiotech ٥ يناير ٢٠٢٦ Insilico, fresh off its Hong Kong IPO, pens potential $888M cancer R&D pact with Servier
FierceBiotech ٢ يناير ٢٠٢٦ Cellular energy booster restores cognition in mice with advanced Alzheimer’s disease
FierceBiotech ٢ يناير ٢٠٢٦ NIH instability grows with exit of neuro director, leaving half of institutes under interim leadership
FierceBiotech ٢ يناير ٢٠٢٦ Sanofi, Corcept surprised by FDA rejections for MS, Cushing's syndrome drugs
FierceBiotech ٢ يناير ٢٠٢٦ Neuralink to kick-start 'high-volume production' of brain-computer interface devices, Elon Musk says